Navigation Links
Advertising to Consumers May Raise Drug Prices
Date:11/24/2009

With Plavix as an example, study finds no added use but higher costs

TUESDAY, Nov. 24 (HealthDay News) -- Direct-to-consumer drug ads may contribute to higher Medicaid costs, according to a new study that examined sales of the widely used antiplatelet drug clopidogrel (Plavix).

The analysis of data from 1999 to 2005 for 27 state Medicaid programs found that direct-to-consumer advertising for clopidogrel did not increase people's use of the drug but appeared to be associated with increased drug costs and Medicaid pharmacy expenditures.

Consumer ads for clopidogrel began in 2001. Between then and 2005, spending on DTCA for clopidogrel in the United States was more than $350 million, an average of $70 million a year. In that same time frame, use of the drug in Medicaid programs did not increase, but cost per unit per quarter increased by 40 cents (12 percent), leading to an additional $40.58 in pharmacy costs per 1,000 Medicaid enrollees per quarter, the study found.

"Overall, this change resulted in an additional $207 million in total pharmacy expenditures," wrote Michael R. Law, of the Centre for Health Services and Policy Research at the University of British Columbia in Vancouver, and his colleagues.

"Consequently, payers and policy makers should ... be concerned about [direct-to-consumer advertising] increasing total drug costs for publicly funded reimbursement programs such as Medicaid and Medicare," the researchers concluded. "Future longitudinal studies should examine other drugs and settings because many other countries are currently considering whether to permit" such ads.

The study is in the Nov. 23 issue of Archives of Internal Medicine.

More information

The U.S. Food and Drug Administration has more about direct-to-consumer drug ads.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Nov. 23, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pitt study finds inequality in tobacco advertising
2. CEOs Need an Advertising Check Up or Second Opinion
3. PCMA Launches New Round of E-Prescribing Advertising
4. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
5. Medifast, Inc. to Unveil New Advertising Campaign Featuring Genie Francis and New Web Features in Early 2008
6. Nurses Unveil New Advertising Campaign Against Schwarzenegger-Nunez Individual Mandate Plan
7. Renaissance Health Publishing, LLC Warns the Public that ConsumerLab.com is Not Independent and Labels the CL Seal of Approval a Worthless, Paid-For Advertising Gimmick
8. American Red Cross Launches 2008 National Public Service Advertising Campaign
9. St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards
10. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
11. CBS Outernet Partners With Lifeclinic International to Bring Interactive Health Programming and Advertising to Pharmacy Locations Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum ... allows anyone, anywhere to track their cognitive health, and share results with their physicians. ... brain health on the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively new statin, ... not known to have significant interactions with antiretroviral therapy (ART). Among people ... and dampen inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study of ... student well-being has seriously declined. "When disenfranchised youth from the heart of our ... State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle East ...
(Date:4/24/2017)... ... ... Life of Purpose Treatment is proud to present “An Evening for Collegiate Recovery ... on May 10th at the University Auditorium. , This benefit concert, featuring Dr. Cheryl ... Collegiate Recovery Community (UFCRC). The concert will kick off the 5th Annual Southeastern CRC ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: